<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>ganciclovir</title><link>http://www.unboundmedicine.com/medline/ebm/research/ganciclovir</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Staphylococcus aureus Endophthalmitis: Antibiotic Susceptibilities, Methicillin Resistance, and Clinical Outcomes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19926069/full_citation/Staphylococcus_aureus_Endophthalmitis:_Antibiotic_Susceptibilities_Methicillin_Resistance_and_Clinical_Outcomes_</link><description>Major JC, Engelbert M, Flynn HW, et al. <br/><span class="title">Staphylococcus aureus Endophthalmitis: Antibiotic Susceptibilities, Methicillin Resistance, and Clinical Outcomes. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of ophthalmology">Am J Ophthalmol 2009 Nov 17.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19926069/abstract/Staphylococcus_aureus_Endophthalmitis:_Antibiotic_Susceptibilities_Methicillin_Resistance_and_Clinical_Outcomes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19926069/full_citation/Staphylococcus_aureus_Endophthalmitis:_Antibiotic_Susceptibilities_Methicillin_Resistance_and_Clinical_Outcomes_">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S0002-9394(09)00626-6">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19926069/Staphylococcus_aureus_Endophthalmitis:_Antibiotic_Susceptibilities_Methicillin_Resistance_and_Clinical_Outcomes_">Find Related Articles</a> </description></item><item><title>Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19924084/full_citation/Bystander_or_No_Bystander_for_Gene_Directed_Enzyme_Prodrug_Therapy_</link><description>Dachs GU, Hunt MA, Syddall S, et al. <br/><span class="title">Bystander or No Bystander for Gene Directed Enzyme Prodrug Therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecules (Basel, Switzerland)">Molecules 2009; 14(11):4517-4545.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19924084/abstract/Bystander_or_No_Bystander_for_Gene_Directed_Enzyme_Prodrug_Therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19924084/full_citation/Bystander_or_No_Bystander_for_Gene_Directed_Enzyme_Prodrug_Therapy_">Full Citation</a></description></item><item><title>Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adult.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918310/full_citation/Severe_exertional_dyspnea_as_the_prime_manifestation_of_acute_cytomegalovirus_infection_in_an_immunocompetent_adult_</link><description>Pagourelias ED, Papageorgiou A, Basayannis E, et al. <br/><span class="title">Severe exertional dyspnea as the prime manifestation of acute cytomegalovirus infection in an immunocompetent adult. [Journal Article]</span><br/><span class="source" title="Hippokratia">Hippokratia 2009 Jul; 13(3):181-3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918310/abstract/Severe_exertional_dyspnea_as_the_prime_manifestation_of_acute_cytomegalovirus_infection_in_an_immunocompetent_adult_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918310/full_citation/Severe_exertional_dyspnea_as_the_prime_manifestation_of_acute_cytomegalovirus_infection_in_an_immunocompetent_adult_">Full Citation</a></description></item><item><title>Postural epigastric pain as a sign of cytomegalovirus gastritis in renal transplant recipients: a case-based review.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917423/full_citation/Postural_epigastric_pain_as_a_sign_of_cytomegalovirus_gastritis_in_renal_transplant_recipients:_a_case_based_review_</link><description>Li W, Fan H, Yiping L <br/><span class="title">Postural epigastric pain as a sign of cytomegalovirus gastritis in renal transplant recipients: a case-based review. [Journal Article]</span><br/><span class="source" title="Transplantation proceedings">Transplant Proc 2009 Nov; 41(9):3956-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917423/abstract/Postural_epigastric_pain_as_a_sign_of_cytomegalovirus_gastritis_in_renal_transplant_recipients:_a_case_based_review_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917423/full_citation/Postural_epigastric_pain_as_a_sign_of_cytomegalovirus_gastritis_in_renal_transplant_recipients:_a_case_based_review_">Full Citation</a></description></item><item><title>Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19896764/full_citation/Enhanced_antitumor_effects_by_combination_gene_therapy_using_MDR1_gene_shRNA_and_HSV1_tk_in_a_xenograft_mouse_model_</link><description>Lee SW, Lee YL, Lee YJ, et al. <br/><span class="title">Enhanced antitumor effects by combination gene therapy using MDR1 gene shRNA and HSV1-tk in a xenograft mouse model. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cancer letters">Cancer Lett 2009 Nov 5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19896764/abstract/Enhanced_antitumor_effects_by_combination_gene_therapy_using_MDR1_gene_shRNA_and_HSV1_tk_in_a_xenograft_mouse_model_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19896764/full_citation/Enhanced_antitumor_effects_by_combination_gene_therapy_using_MDR1_gene_shRNA_and_HSV1_tk_in_a_xenograft_mouse_model_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19896764/Enhanced_antitumor_effects_by_combination_gene_therapy_using_MDR1_gene_shRNA_and_HSV1_tk_in_a_xenograft_mouse_model_">Find Related Articles</a> </description></item><item><title>Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19896083/full_citation/Incidence_of_Viral_and_fungal_infections_following_busulfan_based_reduced_intensity_versus_myeloablative_conditioning_in_pediatric_allogeneic_stem_cell_transplantation_recipients_</link><description>Satwani P, Baldinger L, Freedman J, et al. <br/><span class="title">Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients. [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation">Biol Blood Marrow Transplant 2009 Dec; 15(12):1587-95.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19896083/abstract/Incidence_of_Viral_and_fungal_infections_following_busulfan_based_reduced_intensity_versus_myeloablative_conditioning_in_pediatric_allogeneic_stem_cell_transplantation_recipients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19896083/full_citation/Incidence_of_Viral_and_fungal_infections_following_busulfan_based_reduced_intensity_versus_myeloablative_conditioning_in_pediatric_allogeneic_stem_cell_transplantation_recipients_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19896083/Incidence_of_Viral_and_fungal_infections_following_busulfan_based_reduced_intensity_versus_myeloablative_conditioning_in_pediatric_allogeneic_stem_cell_transplantation_recipients_">Find Related Articles</a> </description></item><item><title>Testing the susceptibility of human herpesviruses to antivirals.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19895215/full_citation/Testing_the_susceptibility_of_human_herpesviruses_to_antivirals_</link><description>Agut H, Boutolleau D, Deback C, et al. <br/><span class="title">Testing the susceptibility of human herpesviruses to antivirals. [Journal Article]</span><br/><span class="source" title="Future microbiology">Future Microbiol 2009 Nov.:1111-23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19895215/abstract/Testing_the_susceptibility_of_human_herpesviruses_to_antivirals_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19895215/full_citation/Testing_the_susceptibility_of_human_herpesviruses_to_antivirals_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19895215/Testing_the_susceptibility_of_human_herpesviruses_to_antivirals_">Find Related Articles</a> </description></item><item><title>Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19889123/full_citation/Clinical_Predictors_of_Relapse_after_Treatment_of_Primary_Gastrointestinal_Cytomegalovirus_Disease_in_Solid_Organ_Transplant_Recipients_</link><description>Eid AJ, Arthurs SK, Deziel PJ, et al. <br/><span class="title">Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons">Am J Transplant 2009 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19889123/abstract/Clinical_Predictors_of_Relapse_after_Treatment_of_Primary_Gastrointestinal_Cytomegalovirus_Disease_in_Solid_Organ_Transplant_Recipients_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19889123/full_citation/Clinical_Predictors_of_Relapse_after_Treatment_of_Primary_Gastrointestinal_Cytomegalovirus_Disease_in_Solid_Organ_Transplant_Recipients_">Full Citation</a> | <a href="http://dx.doi.org/10.1111/j.1600-6143.2009.02861.x">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19889123/Clinical_Predictors_of_Relapse_after_Treatment_of_Primary_Gastrointestinal_Cytomegalovirus_Disease_in_Solid_Organ_Transplant_Recipients_">Find Related Articles</a> </description></item><item><title>Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19887556/full_citation/Positive_selection_of_gene_modified_cells_increases_the_efficacy_of_pancreatic_cancer_suicide_gene_therapy_</link><description>Martinez-Quintanilla J, Cascallo M, Gros A, et al. <br/><span class="title">Positive selection of gene-modified cells increases the efficacy of pancreatic cancer suicide gene therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="Molecular cancer therapeutics">Mol Cancer Ther 2009 Nov 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19887556/abstract/Positive_selection_of_gene_modified_cells_increases_the_efficacy_of_pancreatic_cancer_suicide_gene_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19887556/full_citation/Positive_selection_of_gene_modified_cells_increases_the_efficacy_of_pancreatic_cancer_suicide_gene_therapy_">Full Citation</a></description></item><item><title>Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19885548/full_citation/Use_of_genetically_engineered_bone_marrow_derived_mesenchymal_stem_cells_for_glioma_gene_therapy_</link><description>Amano S, Li S, Gu C, et al. <br/><span class="title">Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. [JOURNAL ARTICLE]</span><br/><span class="source" title="International journal of oncology">Int J Oncol 2009 Dec; 35(6):1265-1270.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19885548/abstract/Use_of_genetically_engineered_bone_marrow_derived_mesenchymal_stem_cells_for_glioma_gene_therapy_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19885548/full_citation/Use_of_genetically_engineered_bone_marrow_derived_mesenchymal_stem_cells_for_glioma_gene_therapy_">Full Citation</a></description></item></channel></rss>